C1QBP and hepatocellular carcinoma: In addition, it is of significance to investigate mechanisms that contribute to these genetic or epigenetic alterations of C1QBP, which may aid to pharmaceutically modulate the expression of C1QBP or identify novel biomarkers for HCC patients.